The London Cancer Hub has been identified as a key district for ‘frontier innova...
Biotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as...
Prilenia has signed a partnership and licence agreement with Ferrer for jointly ...
The EC has granted conditional marketing approval to Regeneron Pharmaceuticals’ ...
In early 2025, US President Donald Trump mentioned the possibility of potential ...
MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmi...
While the pharmaceutical industry is currently exempt from US tariffs, there is ...
Companies are developing myostatin inhibitors for GLP-1RA-related muscle loss, b...
CEO Soriot said Europe must boost investment in pharma innovation or risk fallin...
Funding troubles and innovation responsibilities are falling more heavily on eme...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted ma...
China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-lin...
Granite Bio has secured $100m in funding for its new antibody treatments that ta...
The EC has granted orphan drug designation to Dyne Therapeutics’ DYNE-251 for tr...
The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncer...
MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufact...
